The pandemic has caused problems in the forefront of predictability and access to medicines in the country. It was difficult to supply the basic (active) substances for pharmaceutical production, and a slight increase in the production of drugs.

In this context, even before the first global lockdown, the team of Tchaikapharma has prepared a stategy for action in the unprecedented situation, by defining three main challenges.

The full article is available here in Bulgarian.